Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Endometrial Neoplasms 2Breast Neoplasms 2TP53 Y220C Mutation 1Smoking 1Rectal Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Peripheral Nervous System Diseases 1Overweight 1Obesity 1Motor Activity 1Meningioma 1Medulloblastoma 1Lymphoma, Mantle-Cell 1Lymphoma 1Localized Prostate Cancer 1Leukemia, Myeloid, Acute 1Leukemia 1Infertility 1HER2 IHC3+ Advanced Colorectal Cancer 1Genetic Diseases, Inborn 1Cognitive Dysfunction 1

Interventions

Magnetic Resonance Spectroscopy 2Tablets 1Fulvestrant 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genetic Diseases, Inborn × Tablets × 90 days × Clear all
NCT05392608 2026-05-22

SEQUEL-Breast

Borstkanker Onderzoek Groep

Phase 2 Active not recruiting
130 enrolled
Breast

Breast Neoplasms, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡